AGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Allergan PLC's quarterly accounts payable increased from Sep. 2014 ($3,949 Mil) to Dec. 2014 ($4,221 Mil) and increased from Dec. 2014 ($4,221 Mil) to Mar. 2015 ($5,922 Mil).
Allergan PLC's annual accounts payable declined from Dec. 2012 ($2,536 Mil) to Dec. 2013 ($2,440 Mil) but then increased from Dec. 2013 ($2,440 Mil) to Dec. 2014 ($4,221 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Allergan PLC Annual Data
Allergan PLC Quarterly Data